COVID-19 and Research

Federal Guidance

Centers for Disease Control and Prevention (CDC)

• Contractor Telework Update (PDF)

Council on Governmental Relations (COGR)

• Institutional and Agency Responses to COVID-19 and Additional Resources
• FAQs Regarding COVID-19’s Impact on Federal Awards

Defense Advanced Research Projects Agency (DARPA)

• FAQs about COVID-19 for DARPA Performers

Department of Energy (DOE)

• Accommodating Interruptions due to COVID-19

Institute of Museum and Library Services (IMLS)

• Managing Your IMLS Award (PDF)

National Institutes of Health (NIH)

• COVID-19 Homepage
• Information for NIH Applicants and Recipients
  • FAQs
  • Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
  • Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
  • Guidance for NIH Funded Clinical Trials and Human Subjects Studies affected by COVID-19
  • Late Application Policy due to COVID-19
• Travel and Meetings
• Emergency Updates
• NCI CIRB
• NIH Extramural Nexus
• NIH Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19 (Video)

National Science Foundation (NSF)

• Coronavirus Home Page
  • FAQs
  • Dear Colleague letter
  • Interim Travel Guidance (PDF)

Office of Management and Budget (OMB)

• OMB guidance to federal agencies (PDF)
• OMB – M-20-17, Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (PDF)

Office on Violence Against Women (OVW)

• COVID-19 FAQs for OVW Grantees Regarding the Payment and Use of Leave for Grant-Funded Staff (PDF)
• Message from OVW Acting Director Regarding COVID-19 (PDF)

United States Army Medical Research Acquisition Activity (USAMRAA)

• USAMRAA COVID-19 FAQs (PDF)

Non-Federal Guidance

• American Heart Association – COVID-19
• Alzheimer’s Association COVID-19 Update (PDF)
• Deaconess Foundation Adjustments and Action (PDF)
• Lupus Therapeutics on COVID-19 (PDF)